Cengild Medical Berhad (KLSE:CENGILD)
0.2300
0.00 (0.00%)
At close: Jan 23, 2026
Cengild Medical Berhad Revenue
Cengild Medical Berhad had revenue of 18.67M MYR in the quarter ending September 30, 2025, a decrease of -15.94%. This brings the company's revenue in the last twelve months to 76.45M, up 7.04% year-over-year. In the fiscal year ending June 30, 2025, Cengild Medical Berhad had annual revenue of 80.00M with 19.72% growth.
Revenue (ttm)
76.45M
Revenue Growth
+7.04%
P/S Ratio
2.45
Revenue / Employee
506.32K
Employees
151
Market Cap
187.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 80.00M | 13.18M | 19.72% |
| Jun 30, 2024 | 66.82M | -3.46M | -4.92% |
| Jun 30, 2023 | 70.28M | 5.84M | 9.06% |
| Jun 30, 2022 | 64.44M | 972.41K | 1.53% |
| Jun 30, 2021 | 63.47M | 24.29M | 62.00% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gadang Holdings Berhad | 949.49M |
| Malton Berhad | 532.10M |
| Advance Synergy Berhad | 278.96M |
| K. Seng Seng Corporation Berhad | 249.10M |
| Homeritz Corporation Berhad | 222.23M |
| LTKM Berhad | 214.18M |
| Analabs Resources Berhad | 125.87M |
| N2N Connect Berhad | 96.88M |